Compare American Well Corp (AMWL) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Axogen Inc — how do they compare? American Well Corp trades at $12.95 (market cap $215.16M), while Axogen Inc trades at $47.92 (market cap $2.67B). The key difference: Axogen Inc is far larger — about 12.4× American Well Corp's market cap. Which is the better fit depends on your goals.
| AMWL | AXGN | |
|---|---|---|
Market Cap | $215.16M | $2.67B |
Sector | Health | Technology |
52-Week High | $13.58 | $49.67 |
52-Week Low | $3.78 | $14.79 |
Enterprise Value | $22.19M | $2.58B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $12.94, down 0.38% with a bullish technical signal. The company shows improving fundamentals with three consecutive quarterly earnings beats and narrowing losses. Revenue declined to $249.33M in 2025 but net losses improved from -$270M to -$95.70M. Recent news highlights Amwell's strategic developments including a Department of Defense contract and leadership changes at Amazon's healthcare unit.
While AMWL shows operational improvement with reduced cash burn and earnings momentum, the stock faces challenges from declining revenue and persistent losses. Analyst consensus leans cautious with 67% hold ratings. Key risks include execution on profitability targets and competitive pressures in telehealth. The path to cash-flow breakeven in Q4 2026 remains critical for valuation upside.
AXGN trades at $49.67, up 2.45% today, showing strong momentum near resistance at $50. The stock maintains a bullish technical outlook with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, revenue growth remains robust with Q2 2026 sales up 23.1% to $69.7 million and full-year guidance raised to at least $279 million, but profitability challenges persist with negative net margins and recent earnings misses.
Analyst consensus remains strongly bullish with 84% buy ratings and a $54.33 price target, representing 9.4% upside potential. Key investment opportunities include expanding nerve care platform adoption and reimbursement improvements, while risks include ongoing profitability challenges, competitive pressures, and reliance on elective procedure recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
